[1]
|
“What Are the Key Statistics about Breast Cancer?” 2013.
http://www.cancer.org/cancer/ breastcancer/ detailedguide/breast-cancer-key-statistics
|
[2]
|
P. M. Frossard, M. J. Malloy, G. G. Lestringant and J. P. Kane, “Haplotypes of the Human Renin Gene Associated with Essential Hypertension and Stroke,” Journal of Human Hypertension, Vol. 15, No. 1, 2001, pp. 49-55.
doi:10.1038/sj.jhh.1001107
|
[3]
|
M. Fujita, I. Hayashi, S. Yamashina, M. Itoman and M. Majima, “Blockade of Angiotensin AT1a Receptor Signaling Reduces Tumor Growth, Angiogenesis, and Metastasis,” Biochemical and Biophysical Research Communications, Vol. 294, No. 2, 2002, pp. 441-447.
doi:10.1016/S0006-291X(02)00496-5
|
[4]
|
S. Greco, A. Muscella, M. G. Elia, et al., “Angiotensin II Activates Extracellular Signal Regulated Kinases via Protein Kinase C and Epidermal Growth Factor Receptor in Breast Cancer Cells,” Journal of Cellular Physiology, Vol. 196, No. 2, 2003, pp. 370-377.
doi:10.1002/jcp.10313
|
[5]
|
F. Deshayes and C. Nahmias, “Angiotensin Receptors: A New Role in Cancer?” Trends in Endocrinology & Metabolism, Vol. 16, No. 7, 2005, pp. 293-299.
doi:10.1016/j.tem.2005.07.009
|
[6]
|
E. I. Ager, J. Neo and C. Christophi, “The Rennin-AngioTensin System and Malignancy,” Carcinogenesis, Vol. 29, No. 9, 2008, pp. 1675-1684. doi:10.1093/carcin/bgn171
|
[7]
|
F. Deshayes and C. Nahmias, “Angiotensin Receptors: A New Role in Cancer?” Trends in Endocrinology & Metabolism, Vol. 16, No. 7, 2005, pp. 293-299.
doi:10.1016/j.tem.2005.07.009
|
[8]
|
R. A. Santos, M. J. Campagnole-Santos and S. P. Andrade, “Angiotensin-(1 -7): An Update,” Regulatory Peptides, Vol. 91, No. 1-3, 2000, pp. 45-62.
doi:10.1016/S0167-0115(00)00138-5
|
[9]
|
I. F. Benter, D. I. Diz and C. M. Ferrari, “Pressor and Reflex Sensitivity Is Altered in Spontaneously Hypertensive Rats Treated with Angiotensin-(1 -7),” Hypertension, Vol. 26, No. 6, 1995, pp. 1138-1144.
doi:10.1161/01.HYP.26.6.1138
|
[10]
|
W. B. Strawn, C. M. Ferrario and E. A. Tallant, “Angiotensin (1 -7) Reduces Smooth Muscle Growth after Vascular Injury,” Hypertension, Vol. 33, No. 1, 1999, pp. 207-211. doi:10.1161/01.HYP.33.1.207
|
[11]
|
E. J. Freeman, G. M. Chisolm, C. M. Ferrario and E. A. Tallant, “Angiotensin-(1 -7) Inhibits Vascular Smooth Muscle Cell Growth,” Hypertension, Vol. 28, No. 1, 1996, pp. 104-108. doi:10.1161/01.HYP.28.1.104
|
[12]
|
E. A. Tallant, C. M. Ferrario and P. E. Gallagher, “Angiotensin-(1 -7) Inhibits Growth of Cardiac Myocytes through Activation of the Mas Receptor,” American Journal of Physiology—Heart and Circulatory Physiology, Vol. 289, No. 4, 2005, pp. H1560-H1566.
doi:10.1152/ajpheart.00941.2004
|
[13]
|
R. D. Machado, R. A. Santos and S. P. Andrade, “Opposing Actions of Angiotensins on Angiogenesis,” Life Sciences, Vol. 66, No. 1, 2000, pp. 67-76.
|
[14]
|
R. A. Santos, K. B. Brosnihan, D. W. Jacobsen, P. E. DiCorletto and C. M. Ferrario, “Production of Angiotensin-(1 -7) by Human Vascular Endothelium,” Hypertension, Vol. 19, No. 2, 1992, pp. 56-61.
|
[15]
|
K. Yamamoto, M. C. Chappell, K. B. Broshinan and C. M. Ferrario, “In Vivo Metabolism of Angiotensin I by Neutral Endopeptidase (EC 3.4.24.11) in Spontaneously Hypertensive Rats,” Hypertension, Vol. 19, No. 6, 1992, pp. 692-696. doi:10.1161/01.HYP.19.6.692
|
[16]
|
M. C. Chappell, E. A. Tallant, K. B. Brosnihan and C. M. Ferrario, “Conversion of Angiotensin I to Angiotensin-(1 -7) by Thimet Oligopeptidase (E.C.3.4.24.15) in Vascular Smooth Muscle Cells,” Journal of Vascular Medicine and Biology, Vol. 5, No. 4, 1994, pp. 129-137.
|
[17]
|
S. R. Tipnis, N. M. Hooper, R. Hyde, E. Karran, G. Christie and A. J. Turner, “A Human Homolog of AngiotensinConverting Enzyme. Cloning and Functional Expression as a Captopril-Insensitive Carboxypeptidase,” The Journal of Biological Chemistry, Vol. 275, No. 43, 2000, pp. 33238-33243. doi:10.1074/jbc.M002615200
|
[18]
|
M. A. Crackower, R. Sarao, G. Y. Oudit, C. Yagil, I. Kozieradzki, S. E. Scanga, et al., “Angiotensin-Converting Enzyme 2 Is an Essential Regulator of Heart Function,” Nature, Vol. 417, No. 6891, 2002, pp. 822-828.
doi:10.1038/nature00786
|
[19]
|
M. Donoghue, F. Hsieh, E. Baronas, K. Godbout, M. Gosselin, N. Stagliano, et al., “A Novel Angiotensin-Converting Enzyme-Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9,” Circulation Research, Vol. 87, No. 5, 2000, pp. E1-E9.
doi:10.1161/01.RES.87.5.e1
|
[20]
|
M. C. Chappell, N. T. Pirro, A. Sykes and C. M. Ferrario, “Metabolism of Angiotensin-(1 -7) by Angiotensin-Converting Enzyme,” Hypertension, Vol. 31, No. 1, 1998, pp. 362-367. doi:10.1161/01.HYP.31.1.362
|
[21]
|
K. Yamada, S. N. Iyer, M. C. Chappell, D. Ganten and C. M. Ferrario, “Converting Enzyme Determines the Plasma Clearance of Angiotensin-(1 -7),” Hypertension, Vol. 32, No. 3, 1998, pp. 496-502. doi:10.1161/01.HYP.32.3.496
|
[22]
|
R. A. Santos, A. C. Simoes e Silva, C. Maric, et al., “Angiotensin-(1 -7) Is an Endogenous Ligand for the G Protein-Coupled Receptor Mas,” Proceedings of the National Academy of Sciences of the United States of America, Vol. 100, No. 14, 2003, pp. 8258-8263.
doi:10.1073/pnas.1432869100
|
[23]
|
C. R. Nakaie, E. G. Silva, E. M. Cilli, R. Marchetto, S. Schreier, T. B. Paiva and A. C. Paiva, “Synthesis and Pharmacological Properties of TOAC-Labeled Angiotensin and Bradykinin Analogs,” Peptides, Vol. 23, No. 1, 2002, pp. 65-70.
|
[24]
|
G. N. Jubilut, E. M. Cilli, E. Crusca, E. H. Silva, Y. Okada and C. R. Nakaie, “Comparative Investigation of the Cleavage Step in the Synthesis of Model Peptide Resins: Implications for Nalpha-9-Fluorenylmethyloxycarbonyl-Solid Phase Peptide Synthesis,” Chemical & Pharmaceutical Bulletin (Tokyo), Vol. 55, No. 3, 2007, pp. 468-470.
|
[25]
|
D. E. Morbeck, P. C. Roche, H. T. Keutmann and D. J. McCormick, “A Receptor Binding Site Identified in the Region 81-95 of the Beta-Subunit of Human Luteinizing Hormone (LH) and Chorionic Gonadotropin (hCG),” Molecular and Cellular Endocrinology, Vol. 97, No. 1-2, 1993, pp. 173-181.
|
[26]
|
S. M. R. Noronha, S. A. A. Correa-Noronha, I. H. Russo, R. L. di Cicco, J. Santucci-Pereira and J. Russo, “Human Chorionic Gonadotropin and a 15 Amino Acid hCG Fragment of the Hormone Induce Downregulation of the Cytokine IL-8 Receptor in Normal Breast Epithelial Cells,” Hormone Molecular Biology and Clinical Investigation, Vol. 6, No. 3, 2011, pp. 241-245.
|
[27]
|
Y. Zhao, X. Chen, L. Cai, Y. Yang, G. Sui and S. Fu, “Angiotensin II/angiotensin II Type I Receptor (AT1R) Signaling Promotes MCF-7 Breast Cancer Cells Survival via PI3-Kinase/Akt Pathway,” Journal of Cellular Physiology, Vol. 225, No. 1, 2010, pp. 168-173.
|
[28]
|
W. J. Petty, M. Aklilu, V. A. Varela, J. Lovato, P. D. Savage and A. A. Miller, “Reverse Translation of Phase I Biomarker Findings Links the Activity of Angiotensin-(1 -7) to Repression of Hypoxia Inducible Factor-1Alpha in Vascular Sarcomas,” BMC Cancer, Vol. 12, No. 1, 2012, p. 404.
|